My Speaker List
Select Category

After the Nobel, What Next for CRISPR Gene-editing Therapies?

CRISPR has transformed the possibilities for curing diseases caused by one or several genetic mutations. Clinical trials for therapies that utilize the genome editing technology are already underway for debilitating conditions such as sickle-cell anaemia, delivering treatments in disease areas where none currently exist.

Jennifer Doudna wins 2020 Nobel Prize

Awards , CRISPR
Innovative Genomics Institute founder and University of California, Berkeley, biochemist Jennifer Doudna today won the 2020 Nobel Prize in Chemistry with collaborator Emmanuelle Charpentier for their co-development of CRISPR-Cas9, a genome editing breakthrough that allows scientists to rewrite DNA, the code of life.